IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 158 filers reported holding IMMUNOGEN INC in Q4 2016. The put-call ratio across all filers is 5.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $83,000 | -91.2% | 40,731 | -88.4% | 0.05% | -91.7% |
| Q3 2016 | $942,000 | -13.0% | 351,565 | 0.0% | 0.65% | -18.8% |
| Q2 2016 | $1,083,000 | -24.5% | 351,565 | +108.9% | 0.80% | -24.2% |
| Q1 2016 | $1,434,000 | -37.5% | 168,315 | -0.4% | 1.05% | -37.7% |
| Q4 2015 | $2,293,000 | +43.0% | 168,990 | +1.2% | 1.69% | +32.5% |
| Q3 2015 | $1,603,000 | -32.8% | 167,025 | +0.7% | 1.27% | -25.2% |
| Q2 2015 | $2,386,000 | +59.0% | 165,925 | -1.0% | 1.70% | +57.8% |
| Q1 2015 | $1,501,000 | +124.4% | 167,665 | +52.9% | 1.08% | +128.3% |
| Q4 2014 | $669,000 | -34.7% | 109,635 | +13.4% | 0.47% | -34.7% |
| Q3 2014 | $1,024,000 | +7.2% | 96,700 | +20.1% | 0.72% | +6.3% |
| Q2 2014 | $955,000 | -19.9% | 80,525 | -0.9% | 0.68% | -33.4% |
| Q1 2014 | $1,192,000 | 0.0% | 81,225 | 0.0% | 1.02% | 0.0% |
| Q4 2013 | $1,192,000 | – | 81,225 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |